$IMG
Stock $img

$img Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223027816 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q3
Revenue	$782.7K	$648.6K	$600.8K
YoY Change	30.27%	-16.2%	23.99%
Cost Of Revenue	$938.2K	$596.5K	$643.9K
YoY Change	45.7%	-30.46%	-1.53%
Gross Profit	-$155.5K	$52.15K	-$43.11K
YoY Change	260.71%	-162.34%	-74.54%
Gross Profit Margin	-19.87%	8.04%	-7.18%
Selling, General & Admin	$116.6K	$18.04K
YoY Change
% of Gross Profit		34.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$40.65K	$68.69K	$84.29K
YoY Change	-51.77%	-46.76%	-6.07%
% of Gross Profit		131.71%
Operating Expenses	$2.552M	$2.068M	$2.063M
YoY Change	23.74%	-18.8%	-38.19%
Operating Profit	-$2.708M	-$2.016M	-$2.106M
YoY Change	28.59%	-23.36%	-39.95%
Interest Expense	-$2.380K	$1.550K	-$900.00
YoY Change	164.44%	-23.38%	-86.99%
% of Operating Profit
Other Income/Expense, Net	$137.2K	-$11.13K	-$354.1K
YoY Change	-138.75%	-3690.32%	-3609.22%
Pretax Income	-$2.573M	-$2.025M	-$3.136M
YoY Change	-17.95%	-23.1%	-10.49%
Income Tax
% Of Pretax Income
Net Earnings	-$2.573M	-$2.025M	-$3.136M
YoY Change	-17.95%	-23.1%	-10.49%
Net Earnings / Revenue	-328.74%	-312.26%	-521.94%
Basic Earnings Per Share		-$2.63
Diluted Earnings Per Share	-$3.30	-$2.63	-$4.980M
COMMON SHARES
Basic Shares Outstanding	776.7K shares	769.2K shares	23.67M shares
Diluted Shares Outstanding		770.1K shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.373M	$3.280M	$8.315M
YoY Change	-83.49%	-56.4%	-23.12%
Cash & Equivalents	$1.373M	$3.280M	$8.315M
Short-Term Investments
Other Short-Term Assets	$418.2K	$283.3K	$547.8K
YoY Change	-23.65%	-75.88%	17.98%
Inventory	$998.1K	$1.279M	$948.0K
Prepaid Expenses
Receivables	$586.9K	$216.5K	$345.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.376M	$5.060M	$10.16M
YoY Change	-66.76%	-49.17%	-18.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$309.6K	$360.0K	$525.1K
YoY Change	-41.05%	-41.2%	-22.1%
Goodwill
YoY Change
Intangibles	$110.0K	$117.5K	$140.0K
YoY Change	-21.43%	-61.29%
Long-Term Investments	$162.3K	$164.3K	$169.6K
YoY Change	-4.34%	-4.05%	-3.31%
Other Assets	$79.68K	$83.73K	$77.96K
YoY Change	2.2%	-3.48%	-2.33%
Total Long-Term Assets	$1.065M	$1.196M	$1.555M
YoY Change	-31.54%	-50.9%	18.2%
TOTAL ASSETS
Total Short-Term Assets	$3.376M	$5.060M	$10.16M
Total Long-Term Assets	$1.065M	$1.196M	$1.555M
Total Assets	$4.441M	$6.256M	$11.71M
YoY Change	-62.08%	-49.51%	-14.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.904M	$1.152M	$113.7K
YoY Change	1574.39%	152.44%	-66.83%
Accrued Expenses	$216.1K	$297.5K	$706.5K
YoY Change	-69.41%	-39.57%	157.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$30.80K	$35.37K	$32.47K
YoY Change	-5.14%	-8.13%	-54.56%
Total Short-Term Liabilities	$2.556M	$1.879M	$1.600M
YoY Change	59.78%	22.81%	38.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$3.800K	$34.37K
YoY Change	-100.0%	-89.57%	-45.67%
Other Long-Term Liabilities	$47.94K	$47.22K	$66.48K
YoY Change	-27.9%	-41.57%	1.04%
Total Long-Term Liabilities	$210.2K	$214.2K	$368.6K
YoY Change	-42.97%	-68.64%	-2.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.556M	$1.879M	$1.600M
Total Long-Term Liabilities	$210.2K	$214.2K	$368.6K
Total Liabilities	$2.767M	$2.093M	$1.969M
YoY Change	40.54%	-5.41%	28.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.37M	-$70.80M	-$64.62M
YoY Change	13.54%	15.15%	22.33%
Common Stock	$74.93M	$74.82M	$74.28M
YoY Change	0.87%	4.67%	14.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.674M	$4.163M	$9.743M
YoY Change
Total Liabilities & Shareholders Equity	$4.441M	$6.256M	$11.71M
YoY Change	-62.08%	-49.51%	-14.78%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q3
OPERATING ACTIVITIES
Net Income	-$2.573M	-$2.025M	-$3.136M
YoY Change	-17.95%	-23.1%	-10.49%
Depreciation, Depletion And Amortization	$40.65K	$68.69K	$84.29K
YoY Change	-51.77%	-46.76%	-6.07%
Cash From Operating Activities	-$1.896M	-$1.375M	-$1.785M
YoY Change	6.24%	-9.73%	-6.19%
INVESTING ACTIVITIES
Capital Expenditures	-$13.76K	$18.37K	$22.75K
YoY Change	-160.48%	-137.62%	-12.8%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$13.76K	-$18.37K	$22.76K
YoY Change	-39.54%	-79.14%	-12.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-6.030K	-6.100K	2.648M
YoY Change	-100.23%	-100.63%	-12215.0%
NET CHANGE
Cash From Operating Activities	-1.896M	-1.375M	-1.785M
Cash From Investing Activities	13.76K	-18.37K	22.76K
Cash From Financing Activities	-6.030K	-6.100K	2.648M
Net Change In Cash	-1.889M	-1.399M	886.3K
YoY Change	-313.09%	117.51%	-146.69%
FREE CASH FLOW
Cash From Operating Activities	-$1.896M	-$1.375M	-$1.785M
Capital Expenditures	-$13.76K	$18.37K	$22.75K
Free Cash Flow	-$1.883M	-$1.393M	-$1.808M
YoY Change	4.15%	-5.5%	-6.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001527613
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q4	NUZE	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	NUZE	Proceeds From Issuance Of Common Stock Exercise Of Warrants Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockExerciseOfWarrantsNetOfIssuanceCosts		usd
	NUZE	Proceeds From Issuance Of Equity Securities Exempt Offering Net Of Issuance Costs ProceedsFromIssuanceOfEquitySecuritiesExemptOfferingNetOfIssuanceCosts		usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	NUZE	Forgiveness Of Stock Issuance Costs ForgivenessOfStockIssuanceCosts		usd
	NUZE	Stock Issuance Cost Accrued StockIssuanceCostAccrued		usd
	NUZE	Addition For Right Of Use Of Assets AdditionForRightOfUseOfAssets		usd
	NUZE	Addition For Lease Liability AdditionForLeaseLiability		usd
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited
	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q3	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q2	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
CY2023Q2	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Exercisable Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsExercisableAggregateIntrinsicValueNonvested		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39338
	dei	Entity Registrant Name EntityRegistrantName	NUZEE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3849791
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1350 East Arapaho Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite #230
	dei	Entity Address City Or Town EntityAddressCityOrTown	Richardson
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75081
	dei	City Area Code CityAreaCode	(760)
	dei	Local Phone Number LocalPhoneNumber	295-2408
	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value
	dei	Trading Symbol TradingSymbol	NUZE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	776739	shares
CY2023Q2	us-gaap	Cash Cash	3280425	usd
CY2022Q3	us-gaap	Cash Cash	8315053	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	216515	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	345258	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1279300	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	283292	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	547773	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	5059532	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	10156079	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	360010	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	525075	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	470906	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	642624	usd
CY2023Q2	us-gaap	Investments Investments	164284	usd
CY2022Q3	us-gaap	Investments Investments	169634	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	117500	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	140000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	83730	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77962	usd
CY2023Q2	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	836420	usd
CY2022Q3	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	1030220	usd
CY2023Q2	us-gaap	Assets Assets	6255962	usd
CY2022Q3	us-gaap	Assets Assets	11711374	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1152327	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	820200	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	4759	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	7947	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	297541	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	388325	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	30610	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24518	usd
CY2023Q2	us-gaap	Deferred Income Current DeferredIncomeCurrent	348641	usd
CY2022Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	319707	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	45160	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39241	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1879038	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2067915	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1599938	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	163204	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	267786	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1801	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	29622	usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	2001	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	4745	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	47223	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	66484	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	214229	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	368637	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2093267	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1968575	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	776739	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	776739	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	676229	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	676229	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	8	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	7	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74824442	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74281418	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70798936	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64622520	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	137181	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	83894	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4162695	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9742799	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6255962	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11711374	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	648607	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	774019	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2566121	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2508345	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	596454	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	857672	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2401806	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2575646	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	52153	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	-83653	usd
	us-gaap	Gross Profit GrossProfit	164315	usd
	us-gaap	Gross Profit GrossProfit	-67301	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2546608	usd
	us-gaap	Operating Expenses OperatingExpenses	6328044	usd
	us-gaap	Operating Expenses OperatingExpenses	8554276	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2015762	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2630261	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6163729	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8621577	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1853	usd
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1919	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5350	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4215	usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	50713	usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	60672	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	163915	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	145890	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	61841	usd
CY2022Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	60361	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	187018	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	174889	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	3406	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2023	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15766	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-7001	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2025337	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2633892	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6176416	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8661792	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.63
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.63
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.77
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-16.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-16.41
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	770063	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	770063	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	552364	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	552364	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	716388	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	716388	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	527868	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	527868	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2025337	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2633892	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-19331	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-45197	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19331	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45197	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2044668	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2679089	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6176416	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8661792	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	53287	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-19604	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	53287	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19604	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6123129	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8681396	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9742799	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	197108	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	62839	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	115583	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2183206	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7935123	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	57120	shares
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	25000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-114482	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	51940	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42965	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967873	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5943863	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	78750	shares
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	15000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	107754	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	61996	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19331	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2025337	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4162695	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	12212447	usd
CY2021Q4	NUZE	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	1721018	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1124187	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	32688	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-2804203	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12286137	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	18422	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	88426	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	386844	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	935447	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12600	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	9590	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7095	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3223697	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10469830	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10469830	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6830	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1649736	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	40000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	627895	usd
CY2022Q2	NUZE	Adjustment To Additional Paid In Capital Amortization Of Restricted Stock Award Issued AdjustmentToAdditionalPaidInCapitalAmortizationOfRestrictedStockAwardIssued	62326	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45197	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2633892	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10177528	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10177528	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6176416	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8661792	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	181332	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	295178	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	171718	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	213539	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	190380	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2687529	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	135870	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	176775	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	71916	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	109302	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-41108	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-12618	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5350	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4215	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-19441	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18752	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	331305	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	99452	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-264481	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	49464	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5768	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	6926	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	378046	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-93223	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	28934	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	162495	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-195366	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-210194	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-19261	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	15015	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5025379	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5677298	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34875	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	214524	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	413069	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34875	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-627593	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12600	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	5932	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	41671	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	21729	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	18094	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	95256	usd
	NUZE	Proceeds From Issuance Of Common Stock Exercise Of Warrants Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockExerciseOfWarrantsNetOfIssuanceCosts	1702596	usd
	NUZE	Proceeds From Issuance Of Equity Securities Exempt Offering Net Of Issuance Costs ProceedsFromIssuanceOfEquitySecuritiesExemptOfferingNetOfIssuanceCosts	1649736	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	368783	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27661	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3031640	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53287	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-19604	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5034628	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3292855	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8315053	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10815954	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3280425	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7523099	usd
	us-gaap	Interest Paid Net InterestPaidNet	3760	usd
	us-gaap	Interest Paid Net InterestPaidNet	7077	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	558371	usd
	us-gaap	Stock Issued1 StockIssued1	426844	usd
	NUZE	Forgiveness Of Stock Issuance Costs ForgivenessOfStockIssuanceCosts	40000	usd
	NUZE	Stock Issuance Cost Accrued StockIssuanceCostAccrued	273762	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	297541	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	163204	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	460745	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	l-for-35 reverse stock split
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	253862	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	277327	shares
CY2023Q2	us-gaap	Cash Cash	3280425	usd
CY2023Q2	NUZE	Working Capital WorkingCapital	3180494	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	642624	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	171718	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	470906	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	656111	usd
	NUZE	Operating Lease Lease Liability Amortization Expense OperatingLeaseLeaseLiabilityAmortizationExpense	195366	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	460745	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	373061	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	100712	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	473773	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13028	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	460745	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	297541	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	163204	usd
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M24D
CY2023Q2	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.1275	pure
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3760	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	33113	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2759	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	35872	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3461	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	32411	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	30610	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1801	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	263950	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3247	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	21729	usd
	us-gaap	Sublease Income SubleaseIncome	133443	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	53287	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	19604	usd
CY2023Q2	NUZE	Sub Lease Liability Payments Due Next Twelve Months SubLeaseLiabilityPaymentsDueNextTwelveMonths	129835	usd
CY2023Q2	NUZE	Minimum Lease Payments To Be Received Sublease MinimumLeasePaymentsToBeReceivedSublease	129835	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	283292	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	547773	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	283292	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	547773	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1279300	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1212360	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	887632	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	66940	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	60363	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1279300	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5350	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4215	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2566121	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2508345	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	360010	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	525075	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	531412	usd
CY2022Q3	us-gaap	Goodwill Goodwill	0	usd
CY2022	NUZE	Non Cash Impairment Charges For The Dripkit Tradename NonCashImpairmentChargesForTheDripkitTradename	80555	usd
CY2022	NUZE	Non Cash Impairment Charges For Acquried Customer NonCashImpairmentChargesForAcquriedCustomer	63167	usd
CY2022Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	774019	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2585802	usd
CY2022Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	2624975	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	8491254	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22500	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	2458	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12186	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	113650	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	149.88
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1207	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12186	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	118.02
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	101464	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	154.48
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M10D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	70146	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	174.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y11M8D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	50009	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	154.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	8883	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	107.79
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	9808	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	253.71
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	31318	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	138.20
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	152398	shares
CY2022Q3	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	158.24
CY2022	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P3Y8M12D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	152398	shares
CY2023Q2	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	158.24
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Ending Balance SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermEndingBalance	P2Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther	152398	shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercisable In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisableInPeriodWeightedAverageExercisePrice	158.24
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermExercisable	P2Y10M24D
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	150000	usd

Files In Submission

Name	View Source	Status
0001493152-23-027816-index-headers.html	Edgar Link	pending
0001493152-23-027816-index.html	Edgar Link	pending
0001493152-23-027816.txt	Edgar Link	pending
0001493152-23-027816-xbrl.zip	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuze-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nuze-20230630_cal.xml	Edgar Link	unprocessable
nuze-20230630_def.xml	Edgar Link	unprocessable
nuze-20230630_lab.xml	Edgar Link	unprocessable
nuze-20230630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IMG
Stock $img

2023 Q3 Form 10-Q Financial Statement

#000149315223027816 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG Stock $img

2023 Q3 Form 10-Q Financial Statement

#000149315223027816 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG
Stock $img